Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Director departure
CC transcript
Inv. presentation

ISTA PHARMACEUTICALS INC (ISTA) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/15/2012 4 MCGINLEY KATHLEEN (VP, HR and Corp. Services) has filed a Form 4 on ISTA PHARMACEUTICALS INC
06/15/2012 4 McNamara Timothy (VP Clinical Research & Medical) has filed a Form 4 on ISTA PHARMACEUTICALS INC
06/15/2012 4 HUTT PETER BARTON (Director) has filed a Form 4 on ISTA PHARMACEUTICALS INC
06/15/2012 4 ROE WAYNE I (Director) has filed a Form 4 on ISTA PHARMACEUTICALS INC
06/15/2012 4 ANIDO VICENTE JR (President & CEO) has filed a Form 4 on ISTA PHARMACEUTICALS INC
Txns: Disposed/sold 537,116 shares @ $9.1, valued at $4.9M
Disposed/sold 172,775 shares @ $9.1, valued at $1.6M
Disposed/sold 13,613 shares @ $9.1, valued at $123.9k
Disposed/sold 13,612 shares @ $9.1, valued at $123.9k
Disposed/sold 236,350 options to buy @ $3.75, valued at $886.3k
Disposed/sold 17,852 options to buy @ $6.82, valued at $121.8k
Disposed/sold 145,798 options to buy @ $6.82, valued at $994.3k
Disposed/sold 123,789 options to buy @ $3.63, valued at $449.4k
Disposed/sold 36,758 options to buy @ $3.63, valued at $133.4k
Disposed/sold 30,685 options to buy @ $1.04, valued at $31.9k
Disposed/sold 115,914 options to buy @ $1.04, valued at $120.6k
06/15/2012 4 MCMULLIN KIRK (VP, Operations) has filed a Form 4 on ISTA PHARMACEUTICALS INC
06/15/2012 4 PERLMAN ANDREW J (Director) has filed a Form 4 on ISTA PHARMACEUTICALS INC
06/15/2012 4 WILLIAMS RICHARD C (Director) has filed a Form 4 on ISTA PHARMACEUTICALS INC
Txns: Disposed/sold 116,032 shares @ $9.1, valued at $1.1M
Disposed/sold 20,000 options to buy @ $3.89, valued at $77.8k
Disposed/sold 20,000 options to buy @ $4.58, valued at $91.6k
Disposed/sold 20,000 options to buy @ $4.72, valued at $94.4k
Disposed/sold 11,100 options to buy @ $0.79, valued at $8.8k
Disposed/sold 11,100 options to buy @ $6.9, valued at $76.6k
Disposed/sold 16,000 options to buy @ $6.08, valued at $97.3k
Disposed/sold 16,000 options to buy @ $5.82, valued at $93.1k
Disposed/sold 9,000 options to buy @ $10.75, valued at $96.8k
Disposed/sold 16,250 options to buy @ $6.96, valued at $113.1k
Disposed/sold 32,500 options to buy @ $3.49, valued at $113.4k
06/15/2012 4 Davis Glenn Eugene (VP Legal, Chief Compl. Officer) has filed a Form 4 on ISTA PHARMACEUTICALS INC
06/15/2012 4 Drazba Brian G. (VP, Finance & CAO) has filed a Form 4 on ISTA PHARMACEUTICALS INC
Txns: Disposed/sold 40,487 shares @ $9.1, valued at $368.4k
Disposed/sold 29,935 options to buy @ $3.75, valued at $112.3k
Disposed/sold 1,940 options to buy @ $3.75, valued at $7.3k
Disposed/sold 4,834 options to buy @ $4.58, valued at $22.1k
Disposed/sold 8,500 options to buy @ $4.58, valued at $38.9k
Disposed/sold 5,828 options to buy @ $3.63, valued at $21.2k
Disposed/sold 7,875 options to buy @ $3.71, valued at $29.2k
06/15/2012 4 MITRO THOMAS A (VP, Sales & Marketing) has filed a Form 4 on ISTA PHARMACEUTICALS INC
06/15/2012 4 SILVERNAIL LAUREN P (CFO & VP Corporate Development) has filed a Form 4 on ISTA PHARMACEUTICALS INC
06/15/2012 4 MCGRAW BENJAMIN F III (Director) has filed a Form 4 on ISTA PHARMACEUTICALS INC
06/15/2012 4 MITCHELL DEAN J (Director) has filed a Form 4 on ISTA PHARMACEUTICALS INC
Txns: Disposed/sold 4,932 shares @ $9.1, valued at $44.9k
Disposed/sold 20,000 options to buy @ $3.89, valued at $77.8k
Disposed/sold 20,000 options to buy @ $4.58, valued at $91.6k
Disposed/sold 20,000 options to buy @ $4.72, valued at $94.4k
Disposed/sold 11,100 options to buy @ $0.79, valued at $8.8k
Disposed/sold 11,100 options to buy @ $6.9, valued at $76.6k
Disposed/sold 16,000 options to buy @ $6.08, valued at $97.3k
Disposed/sold 16,000 options to buy @ $5.82, valued at $93.1k
Disposed/sold 32,500 options to buy @ $10.17, valued at $330.5k
06/15/2012 4 GARRETT MARVIN J (Vice President, QC, Compliance) has filed a Form 4 on ISTA PHARMACEUTICALS INC
05/23/2012 4 MITRO THOMAS A (VP, Sales & Marketing) has filed a Form 4 on ISTA PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 28,084 shares @ $9.08, valued at $255k
Paid exercise price by delivering 482 shares @ $9.08, valued at $4.4k
Paid exercise price by delivering 11,433 shares @ $9.08, valued at $103.8k
Paid exercise price by delivering 12,871 shares @ $9.08, valued at $116.9k
Paid exercise price by delivering 10,698 shares @ $9.08, valued at $97.1k
Paid exercise price by delivering 2,489 shares @ $9.08, valued at $22.6k
Paid exercise price by delivering 3,943 shares @ $9.08, valued at $35.8k
Paid exercise price by delivering 837 shares @ $9.08, valued at $7.6k
Exercised 21,731 options to buy @ $1.04, valued at $22.6k
Exercised 1,253 options to buy @ $3.49, valued at $4.4k
Exercised 9,862 options to buy @ $3.63, valued at $35.8k
05/22/2012 4 McNamara Timothy (VP Clinical Research & Medical) has filed a Form 4 on ISTA PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 9,745 shares @ $9.07, valued at $88.4k
Paid exercise price by delivering 14,110 shares @ $9.07, valued at $128k
Paid exercise price by delivering 5,566 shares @ $9.07, valued at $50.5k
Paid exercise price by delivering 5,450 shares @ $9.07, valued at $49.4k
Paid exercise price by delivering 1,462 shares @ $9.07, valued at $13.3k
Paid exercise price by delivering 5,103 shares @ $9.07, valued at $46.3k
Paid exercise price by delivering 3,232 shares @ $9.07, valued at $29.3k
Exercised 12,752 options to buy @ $1.04, valued at $13.3k
Exercised 12,750 options to buy @ $3.63, valued at $46.3k
Exercised 11,084 options to buy @ $4.46, valued at $49.4k
Exercised 19,934 options to buy @ $6.42, valued at $128k
05/21/2012 4 MCMULLIN KIRK (VP, Operations) has filed a Form 4 on ISTA PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 11,424 shares @ $9.06, valued at $103.5k
Paid exercise price by delivering 7,229 shares @ $9.06, valued at $65.5k
Paid exercise price by delivering 10,217 shares @ $9.06, valued at $92.6k
Paid exercise price by delivering 11,129 shares @ $9.06, valued at $100.8k
Paid exercise price by delivering 9,200 shares @ $9.06, valued at $83.4k
Paid exercise price by delivering 1,423 shares @ $9.06, valued at $12.9k
Paid exercise price by delivering 4,966 shares @ $9.06, valued at $45k
Paid exercise price by delivering 3,351 shares @ $9.06, valued at $30.4k
Exercised 12,396 options to buy @ $1.04, valued at $12.9k
Exercised 18,767 options to buy @ $3.49, valued at $65.5k
Exercised 12,395 options to buy @ $3.63, valued at $45k
05/21/2012 4 GARRETT MARVIN J (Vice President, QC, Compliance) has filed a Form 4 on ISTA PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 20,338 shares @ $9.06, valued at $184.3k
Paid exercise price by delivering 10,595 shares @ $9.06, valued at $96k
Paid exercise price by delivering 8,624 shares @ $9.06, valued at $78.1k
Paid exercise price by delivering 1,708 shares @ $9.06, valued at $15.5k
Paid exercise price by delivering 4,940 shares @ $9.06, valued at $44.8k
Paid exercise price by delivering 1,967 shares @ $9.06, valued at $17.8k
Paid exercise price by delivering 33,630 shares @ $9.06, valued at $304.7k
Exercised 14,878 options to buy @ $1.04, valued at $15.5k
Exercised 87,303 options to buy @ $3.49, valued at $304.7k
Exercised 12,329 options to buy @ $3.63, valued at $44.8k
Exercised 17,518 options to buy @ $4.46, valued at $78.1k
05/14/2012 4 MCGINLEY KATHLEEN (VP, HR and Corp. Services) has filed a Form 4 on ISTA PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 10,898 shares @ $9.09, valued at $99.1k
Paid exercise price by delivering 10,902 shares @ $9.09, valued at $99.1k
Paid exercise price by delivering 9,517 shares @ $9.09, valued at $86.5k
Paid exercise price by delivering 1,540 shares @ $9.09, valued at $14k
Paid exercise price by delivering 5,374 shares @ $9.09, valued at $48.8k
Paid exercise price by delivering 2,696 shares @ $9.09, valued at $24.5k
Exercised 13,462 options to buy @ $1.04, valued at $14k
Exercised 13,458 options to buy @ $3.63, valued at $48.9k
Exercised 19,396 options to buy @ $4.46, valued at $86.5k
Exercised 14,633 options to buy @ $6.77, valued at $99.1k
Exercised 3,594 options to buy @ $6.82, valued at $24.5k
05/10/2012 4 Drazba Brian G. (VP, Finance & CAO) has filed a Form 4 on ISTA PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 7,814 shares @ $9.08, valued at $71k
Paid exercise price by delivering 2,995 shares @ $9.08, valued at $27.2k
Paid exercise price by delivering 1,219 shares @ $9.08, valued at $11.1k
Paid exercise price by delivering 2,144 shares @ $9.08, valued at $19.5k
Exercised 7,492 options to buy @ $3.63, valued at $27.2k
Exercised 19,125 options to buy @ $3.71, valued at $71k
Exercised 2,416 options to buy @ $4.58, valued at $11.1k
Exercised 4,250 options to buy @ $4.58, valued at $19.5k
05/10/2012 4 SILVERNAIL LAUREN P (CFO) has filed a Form 4 on ISTA PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 9,285 shares @ $9.08, valued at $84.3k
Paid exercise price by delivering 39,172 shares @ $9.08, valued at $355.7k
Paid exercise price by delivering 12,826 shares @ $9.08, valued at $116.5k
Paid exercise price by delivering 11,224 shares @ $9.08, valued at $101.9k
Paid exercise price by delivering 1,907 shares @ $9.08, valued at $17.3k
Paid exercise price by delivering 4,502 shares @ $9.08, valued at $40.9k
Paid exercise price by delivering 1,661 shares @ $9.08, valued at $15.1k
Exercised 16,649 options to buy @ $1.04, valued at $17.3k
Exercised 11,262 options to buy @ $3.63, valued at $40.9k
Exercised 18,903 options to buy @ $4.46, valued at $84.3k
Exercised 65,867 options to buy @ $5.4, valued at $355.7k
05/10/2012 4 ANIDO VICENTE JR (President & CEO) has filed a Form 4 on ISTA PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 11,172 shares @ $9.08, valued at $101.4k
Paid exercise price by delivering 11,013 shares @ $9.08, valued at $100k
Paid exercise price by delivering 10,553 shares @ $9.08, valued at $95.8k
Paid exercise price by delivering 10,159 shares @ $9.08, valued at $92.2k
Paid exercise price by delivering 1,953 shares @ $9.08, valued at $17.7k
Paid exercise price by delivering 1,241 shares @ $9.08, valued at $11.3k
Exercised 17,051 options to buy @ $1.04, valued at $17.7k
Exercised 28,653 options to buy @ $3.49, valued at $100k
Exercised 3,103 options to buy @ $3.63, valued at $11.3k
Exercised 22,744 options to buy @ $4.46, valued at $101.4k
Exercised 14,154 options to buy @ $6.77, valued at $95.8k
04/27/2012 4 ROE WAYNE I (Director) has filed a Form 4 on ISTA PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 374 shares @ $5.88, valued at $2.2k
03/23/2012 4 CREDIT SUISSE AG/ (10% Owner) has filed a Form 4 on ISTA PHARMACEUTICALS INC
Txns: Disposed of 674,116 shares @ $0
03/16/2012 4 CREDIT SUISSE AG/ (10% Owner) has filed a Form 4 on ISTA PHARMACEUTICALS INC
Txns: Sold 28,571 shares @ $8.6994, valued at $248.6k
Sold 130,256 shares @ $8.581, valued at $1.1M
Sold 157,043 shares @ $8.5825, valued at $1.3M
Sold 145,573 shares @ $8.5159, valued at $1.2M
Sold 4,373 shares @ $8.59, valued at $37.6k
03/12/2012 4 CREDIT SUISSE AG/ (10% Owner) has filed a Form 4 on ISTA PHARMACEUTICALS INC
Txns: Sold 200,886 shares @ $8.3017, valued at $1.7M
Sold 4,373 shares @ $8.3013, valued at $36.3k
Sold 17,391 shares @ $8.3755, valued at $145.7k
03/05/2012 4 Davis Glenn Eugene (VP Legal, Chief Compl. Officer) has filed a Form 4 on ISTA PHARMACEUTICALS INC
03/02/2012 4 CREDIT SUISSE AG/ (10% Owner) has filed a Form 4 on ISTA PHARMACEUTICALS INC
Txns: Disposed of 1,002,553 shares @ $0
02/01/2012 4 Davis Glenn Eugene (VP Legal, Chief Compl. Officer) has filed a Form 4 on ISTA PHARMACEUTICALS INC
12/07/2011 4 MCGRAW BENJAMIN F III (Director) has filed a Form 4 on ISTA PHARMACEUTICALS INC
12/07/2011 4 PERLMAN ANDREW J (Director) has filed a Form 4 on ISTA PHARMACEUTICALS INC
12/07/2011 4 MITCHELL DEAN J (Director) has filed a Form 4 on ISTA PHARMACEUTICALS INC
12/07/2011 4 HUTT PETER BARTON (Director) has filed a Form 4 on ISTA PHARMACEUTICALS INC
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy